Kanvas, developer of electronic vaporizer technology solutions for nicotine, cannabis and cannabidiol (CBD) delivery systems, announced the completion of a strategic investment.
The new investment will fuel the research, development and growth necessary to commercialize the company's proprietary Vapetelligence technology platform and further enable scalability of its products, designed to promote device safety in electronic vaporizers and regulated marketplaces globally.
"Kanvas is excited to work with BTV as a strategic investor to advance the commercialization of our unique IP portfolio and technology platform, focusing on our patented and temperature-controlled dosing technology and hardware that provides a secure and controlled delivery system for brands," said Andy Fathollahi, CEO, Kanvas. "Kanvas's pioneering innovations will be a catalyst for brands to support better, safer consumer experiences through integrating higher quality software and smart-chip technology."
Kanvas has a portfolio of patents in technology, software, and hardware products to offer brands a suite of premium solutions for electronic CBD, cannabis,and nicotine delivery systems, including its proprietary temperature-controlled dosing technology and software platform.